1. P2I2 group, Protein Phosphorylation and Human Disease Laboratory, Station Biologique de Roscoff, Centre National de la Recherche Scientifique (CNRS) and Université Pierre et Marie Curie (UPMC), Roscoff, France
2. David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA
3. Proteomics Platform, Centre Hospitalier Universitaire de Québec (CHUQ), Québec, Canada
4. Universitätsmedizin Göttingen, Department of Child and Adolescent Health, Division of Neuropediatrics, Göttingen, Germany